Apolipoprotein disorders.
D000012:Abetalipoproteinemia / Q000503:physiopathology; D016632:Apolipoprotein A-I; D053304:Apolipoprotein C-II; D001053:Apolipoproteins / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D001054:Apolipoproteins A; D001055:Apolipoproteins B; D001056:Apolipoproteins C; D001057:Apolipoproteins E; D055598:Chemical Phenomena; D002621:Chemistry; D014644:Genetic Variation; D006720:Homozygote; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000503:physiopathology; D006952:Hyperlipoproteinemia Type III / Q000175:diagnosis / Q000235:genetics; D006951:Hyperlipoproteinemias / Q000503:physiopathology*; D007009:Hypolipoproteinemias / Q000503:physiopathology*; D008074:Lipoproteins / Q000097:blood; D008075:Lipoproteins, HDL / Q000097:blood; D013631:Tangier Disease / Q000503:physiopathology; D014280:Triglycerides / Q000097:blood
D016632:Apolipoprotein A-I; D053304:Apolipoprotein C-II; D001053:Apolipoproteins; D001054:Apolipoproteins A; D001055:Apolipoproteins B; D001056:Apolipoproteins C; D001057:Apolipoproteins E; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D014280:Triglycerides